A Phase II trial of cisplatin and interferon alpha 2b in patients with advanced bladder cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 20, Issue 3, 1997, Pages 319-321

  Parnis, Francis X ^a   Olver, Ian N ^a   Sandeman, Tom ^b   Bishop, James F ^b   Laidlaw, Christine ^b  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Alpha interferon; Bladder cancer; Cisplatin

Indexed keywords

ALPHA2B INTERFERON; CISPLATIN;

ADVANCED CANCER; ARTICLE; BLADDER CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DRUG POTENTIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NEUROTOXICITY; PHASE 2 CLINICAL TRIAL; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, TRANSITIONAL CELL; CISPLATIN; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DRUG SYNERGISM; FEMALE; HUMANS; INTERFERON ALFA-2B; MALE; NEOPLASM STAGING; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 0030917653     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199706000-00024     Document Type: Article

References (9)

1. Loehrer PJ, Einhorn LH, Elson PG, et al. A randomised comparison of cisplatin alone or in combination with methotrexate, vinblastine and doxorubicin in patients with metastatic urothelial carcinoma: A cooperative group study. J Clin Oncol 1992;10:1066-73.
2. Harker WG, Meyers FJ, Freiha FS, et al. Cisplatin, methotrexate and vinblastine (CMV): An effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study. J Clin Oncol 1985;3:1463-70.
3. Scher HI, Geller NL, Curley T, et al. Effect of relative cumulative dose intensity on survival of patients with urothelial cancer treated with M-VAC. J Clin Oncol 1993;11:400-7.
4. Seidman AD, Scher H, Gabrilove JL, et al. Dose intensification of M-VAC with recombinant granulocyte stimulating factor as initial therapy in advanced urothelial cancer. J Clin Oncol 1994;11:408-14.
5. Yagoda A. Chemotherapy of urothelial tract tumours. Cancer 1987;60:574-85.
6. Schmitz-Drager BJ, Ebert T. Intravesical treatment of superficial bladder carcinoma with interferons. World Journal of Urology 1986;3:218-23.
7. Torti FM, Shortliffe LD, Williams RD, et al. Alpha interferon in superficial bladder cancer. A Northern California Oncology Group Study. J Clinic Oncol 1988;6:467-83.
8. Marogolin KA, Doroshow JH, Akman S, et al. Phase II trial of cisplatin and Alpha interferon in advanced malignant melanoma. J Clin Oncol 1992;10:1574-8.
9. Miller AB, Hoogstraten, Statquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207-14.